Agenda

Wednesday, April 15

   

8:00 am - 12:00 pm

CMCN Certification Exam
Additional fee applies. Eligibility and application must be approved by March 27, 2020. For more information, please email or call with questions jbeilhart@abmcn.org or 804-527-1905

10:30 am - 7:30 pm

Pre-Registration  
11:00 am - 5:00 pm
 
Exhibit Hall Set Up  

Thursday, April 16

   
7:00 am - 7:40 am Hot Breakfast in Exhibit Hall    
7:40 am - 7:50 am Opening Remarks
Doug Chaet,
Chairman, AAIHDS
 
7:50 am - 8:50 am Keynote
Value-Based Care Enablement: Practical Considerations for Payer/Provider Collaboration
David Gregory, Principal and Healthcare Consulting Practice Leader and Michael Patti, Principal, Health Consulting, Baker Tilly Virchow Krause, LLP
 
8:50 pm - 9:25 pm Break in Exhibit Hall  
 
BUSINESS TRACK
 

HEALTH MANAGEMENT
 

ONCOLOGY
 
9:30 am - 10:30 am Aligning Physician Groups to Maximize Health System Managed Care Performance
Craig D. Pederson, Principal, Insight Health Partners
Informed Decision-Making in the Treatment and Management of Multiple Sclerosis: Optimizing Therapeutic Switching and Sequencing Strategies Patient-Focused Treatment Decisions in Advanced Non-Small Cell Lung Cancer (NSCLC): Expert Strategies in an Evolving Treatment Paradigm
10:30 am - 11:30 am Targeting and Managing "Super-Users" to Maximize Efficiency and Increase Patient Compliance
Mark Carlson, PsyD, Owner/CEO and Steven Girardeau, PsyD, LP, Director of Clinical Services, Mental Health Systems
Current Updates and Advances in Diagnosis and Treatment of Spinal Muscular Atrophy Novel Treatment Advances and Approaches in the Management of Multiple Myeloma: Expert Strategies on the Role of Emerging Therapies and MRD
11:30 am - 12:30 pm Lunch in Exhibit Hall Lunch in Exhibit Hall Lunch in Exhibit Hall
12:35 pm - 1:35 pm 15 Things for PCPs to do to Win in Value-Based Care
Clifford Frank, MHSA, President, Healthcare Management Solutions
New Frontiers in the Treatment and Management of ALS of Amyotrophic Lateral Sclerosis (ALS): Managed Care Considerations in an Evolving Treatment Paradigm Implementing New Data and Evolving Standards in Advanced Breast Cancer: Individualizing Treatment for Improved Clinical and Economic Outcomes
1:35 pm - 2:35 pm Creating Market Leverage with your Provider Sponsored Health Plan: Opportunities and Pitfalls
Gary Scott Davis, Partner, McDermott Will & Emery
Best Practices in the Treatment and Management of Cystic Fibrosis: Recent Updates and Advances in CFTR Modulator Therapy Recent Therapeutic Breakthroughs in the Treatment and Management of Pancreatic Cancer: Expert Strategies for Improved Patient Outcomes
2:35 pm - 3:10 pm Break in Exhibit Hall Break in Exhibit Hall Break in Exhibit Hall
3:10 pm - 4:10 pm Three Pillars for Service Line Success in Value-Based Care
Lynda Mischel, Principal, Veralon
Optimizing Clinical and Economic Outcomes in the Management of Moderate-to-Severe Atopic Dermatitis: Recent Advances and Updates in Biologic Therapy Navigating an Increasingly Complex Treatment Landscape in the Management of Acute Myeloid Leukemia (AML): Improving Clinical and Economic Outcomes
4:10 pm - 5:10 pm Building an Effective Hospital/Medical Group Risk Sharing Program for Global Capitation
David Axene, FSA, FCA, President and Consulting Actuary, Axene Health Partners
Advances in Severe Asthma Management: Improving Outcomes and Control through Personalized Treatment Strategies
 

Exploring New Treatment Paradigms in Prostate Cancer: Current and Emerging Treatment Strategies to Improve Patient Care

5:10 pm - 6:30 pm Reception in Exhibit Hall Reception in Exhibit Hall

Reception in Exhibit Hall

     
Friday, April 17  
7:00 am - 7:40 am Hot Breakfast in Exhibit Hall    
7:40 am - 7:50 am Opening Remarks  
7:50 am - 8:50 am Keynote
"Financial and Strategic Aggregators" Lead a New Type of Healthcare Market Consolidation
Jacque Sokolov, MD, CEO & Chairman, SSB Solutions
 
8:50 am - 9:25 am Break in Exhibit Hall Break in Exhibit Hall

Break in Exhibit Hall

 
BUSINESS TRACK
 

HEALTH MANAGEMENT
 

ONCOLOGY
 
9:30 am - 10:30 am Artificial Intelligence in Medicine - Practical Considerations
Stephen M. Borstelmann, MD
A New Era in the Prevention and Management of Migraine: Recent Therapeutic Advances for Optimized Clinical and Economic Outcomes Best Practices in the Management of Chronic Lymphocytic Leukemia (CLL): Expert Perspectives on Novel Therapies and MRD in an Evolving Treatment Paradigm
10:30 am - 11:30 am Case Study: Crucialist Co-Attribution - Value-Based Emergency Care Model Reduces Hospital Utilization
Nicholas Dodaro, MD, President and CMO, Crucial Care/Guidewell Emergency Medicine Physicians, CMO, Medical Life Holdings
Advances in the Management and Treatment of Hypertriglyceridemia: Exploring Strategies and Outcomes for Reducing Cardiovascular Risk
 
Patient-Focused Treatment Decisions in Metastatic Melanoma: An In-Depth Look at the Role of Checkpoint Inhibitors
11:30 am - 12:30 pm Lunch in Exhibit Hall Lunch in Exhibit Hall Lunch in Exhibit Hall
 
HEALTH MANAGEMENT II
 

HEALTH MANAGEMENT
 

GBEMTI
 
12:35 pm - 1:35 pm Effective Ways to Manage Insomnia: Improving Outcomes though Optimal Treatment Strategies New Treatment Breakthroughs in the Management of HIV: Expert Strategies for Optimized Clinical and Economic Outcomes The Latest Advances in the Biosimilar Landscape: Strategies for Optimal Use to Improve Patient Outcomes
1:35 pm - 2:35 pm Recent Evidence on the Management of Narcolepsy: Improving Outcomes through Expert Treatment Strategies Improving the Clinical and Economic Burden of Primary Immunodeficiency Diseases (PIDD): Managed Care Considerations on Immunoglobulin Replacement Therapy Navigating Recent Advances in the Treatment of Advanced Renal Cell Carcinoma (RCC): Expert Strategies on Immunotherapy in an Evolving Treatment Paradigm
 
2:35 pm - 2:45 pm Break in Exhibit Hall Break in Exhibit Hall Break in Exhibit Hall
2:45 pm - 3:45 pm Novel Treatment Advances and Approaches in the Management of Type 2 Diabetes: A Closer Look at the Evolving Role of SGLT2 Inhibitors New Advances in Treatment of Inflammatory Bowel Disease: Expert Strategies for Optimal Management Evolving Considerations in the Treatment of Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC): Expert Strategies in Immunotherapy
3:45 pm - 4:45 pm Novel Treatment Advances and Approaches in Moderate-to-Severe Rheumatoid Arthritis (RA): Expert Perspectives on an Evolving Treatment Paradigm Recent Updates in the Treatment of Major Depressive Disorder: Breaking Barriers through Personalized Care Addressing the Challenges of Hepatocelluar Carcinoma (HCC) Management: Optimal Treatment Strategies for Improved Patient Outcomes
 


Agenda is subject to change